Results 1 to 10 of about 10,448 (161)
A System Based-Approach to Examine Host Response during Infection with Influenza A Virus Subtype H7N9 in Human and Avian Cells [PDF]
Although the influenza A virus H7N9 subtype circulates within several avian species, it can also infect humans with a severe disease outcome. To better understand the biology of the H7N9 virus we examined the host response to infection in avian and human
Biruhalem Taye +2 more
exaly +7 more sources
Human infection with avian influenza A (H5N1) and (H7N9) viruses causes severe respiratory diseases. PB1-F2 protein is a critical virulence factor that suppresses early type I interferon response, but the mechanism of its action in relation to high ...
Pak-Hin Hinson Cheung +2 more
exaly +6 more sources
H7N9 avian influenza virus (AIV) is an emerging zoonotic pathogen, and it is necessary to develop a differentiating infected from vaccinated animals (DIVA) vaccine for the purpose of eradication. H7N9 subtype AIV hemagglutinin subunit 2 glycoprotein (HA2)
Sujuan Chen, Tao Qin, Hongwei Ma
exaly +4 more sources
Visual detection of human infection with influenza A (H7N9) virus by subtype-specific reverse transcription loop-mediated isothermal amplification with hydroxynaphthol blue dye [PDF]
A rapid and sensitive H7 and N9 subtype-specific reverse transcription loop-mediated isothermal amplification assay was developed respectively for visual detection of human-infected influenza A (H7N9) virus. The reaction was performed in one step in a single tube at 63°C for 60 min with the addition of hydroxynaphthol blue dye before amplification. The
Xiong Ding
exaly +4 more sources
An Investigational Antiviral Drug, DAS181, Effectively Inhibits Replication of Zoonotic Influenza A Virus Subtype H7N9 and Protects Mice From Lethality [PDF]
Human infections caused by avian influenza A virus type subtype H7N9 have been associated with substantial morbidity and mortality. Emergence of virus variants carrying markers of decreased susceptibility to neuraminidase inhibitors was reported.
Henju Marjuki +2 more
exaly +4 more sources
Since human infection with the novel H7N9 avian influenza virus was identified in China in March 2013, the relatively high mortality rate and possibility of human-to-human transmission have highlighted the urgent need for sensitive and specific assays for diagnosis of H7N9 infection.We developed a rapid diagnostic test for the novel avian influenza A ...
Cheng-Feng Qin +2 more
exaly +6 more sources
Accelerated Evolution of H7N9 Subtype Influenza Virus under Vaccination Pressure [PDF]
No avian H7N9 outbreaks have occurred since the introduction of H7N9 inactivated vaccine in the fall of 2017. However, H7N9 is still prevalent in poultry. To surveil the prevalence, genetic characteristics, and antigenic changes of H7N9, over 7000 oropharyngeal and cloaca swab specimens were collected from live poultry markets and farms in 15 provinces
Yifan Wu +10 more
openaire +3 more sources
Influenza virus subtype H7 influenza viruses as well as other influenza virus geographically divided into two distinct genetic lineages, North American (H7N2, H7N3) or Eurasian (H7N7 and H7N3). Unlike the AI virus subtypes H5, since 1997 until now, all the infections caused by the H5 virus has Neuraminidase subtype 1 but H7 subtype of AI virus that ...
NLP Indi Dharmayanti, Bahri S
openaire +2 more sources
RNA-based vaccines are the newest promising alternative to traditional approaches to treat viral diseases. In this study, we obtained mRNA encoding the hemagglutinin of influenza A subtype H7N9 by in vitro transcription and evaluated the efficiency of its translation on the A549 cell line.
O.A. Dobrovolskaya +2 more
openaire +2 more sources
Direct airway delivery of a humanized anti-H7N9 neutralizing antibody broadly protects against divergent H7 influenza viruses in the mouse model [PDF]
Passive administration of broadly neutralizing anti-influenza monoclonal antibodies (mAbs) before or after virus infection can prevent or alleviate disease.
Wang Yu +11 more
doaj +2 more sources

